Alector (ALEC) recently reported that its experimental therapy latozinemab did not meet the main efficacy goal in a late-stage trial for frontotemporal dementia. As a result, multiple follow-up ...
Emma Heming Willis shares caregiving lessons and family strength during Bruce Willis' frontotemporal dementia battle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback